Mackay Shields LLC Heron Therapeutics, Inc. Transaction History

Mackay Shields LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$13.27 - $18.48 $993,591 - $1.38 Million	-74,875 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$14.49 - $20.72 $651,339 - $931,384	-44,951 Reduced 37.51%	74,875 $1.21 Million
Q4 2020 Feb 16, 2021	SELL	$14.61 - $22.14 $143,178 - $216,972	-9,800 Reduced 7.56%	119,826 $2.54 Million
Q3 2020 Nov 04, 2020	BUY	$13.67 - $17.77 $289,804 - $376,724	21,200 Added 19.55%	129,626 $1.92 Million
Q2 2020 Jul 31, 2020	BUY	$10.89 - $21.47 $386,595 - $762,185	35,500 Added 48.68%	108,426 $1.6 Million
Q1 2020 May 08, 2020	BUY	$10.23 - $24.56 $110,484 - $265,248	10,800 Added 17.38%	72,926 $856,000
Q4 2019 Feb 11, 2020	SELL	$17.42 - $26.61 $254,332 - $388,506	-14,600 Reduced 19.03%	62,126 $1.46 Million
Q3 2019 Nov 01, 2019	BUY	$16.36 - $21.39 $29,448 - $38,502	1,800 Added 2.4%	76,726 $1.42 Million
Q2 2019 Aug 13, 2019	BUY	$16.93 - $26.22 $854,135 - $1.32 Million	50,451 Added 206.13%	74,926 $1.39 Million
Q1 2019 May 13, 2019	BUY	$23.15 - $28.34 $11,575 - $14,170	500 Added 2.09%	24,475 $598,000
Q4 2018 Feb 14, 2019	BUY	$22.03 - $32.01 $34,697 - $50,415	1,575 Added 7.03%	23,975 $622,000
Q3 2018 Nov 14, 2018	BUY	$30.0 - $40.85 $672,000 - $915,040	22,400 New	22,400 $709,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $186M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.